Evidence map›Paper›PMID 42588657›Full record

ReviewCancers2026

Molecular Profiling to Guide Fertility Sparing Therapy in Early-Stage Endometrial Cancer: A EORTC Gynaecological Cancer Group Study.

Ramon Yarza, Reyes Oliver-Pérez, Eva Oldenburger, Lawrence Kasherman, Shira Peleg Hasson, José Manuel Estrada-Lorenzo, Beatriz Álvarez-Rodríguez, Alberto Martinez de Lara, Fernanda Herrera, Judith Kroep and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ramon YarzaDrug Development and Phase I Unit, START-CIOCC, University Hospital HM Sanchinarro, 28050 Madrid, Spain.
Reyes Oliver-PérezDepartment of Gynaecologic Oncology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0003-3563-1825
Eva OldenburgerDepartment of Radiation Oncology, University Hospital Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-2141-8313
Lawrence KashermanDepartment of Medical Oncology, Illawarra Cancer Care Centre, Wollongong, NSW 2500, Australia.ORCID 0000-0001-7576-8565
Shira Peleg HassonOncology Department, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.ORCID 0000-0002-3707-1107
José Manuel Estrada-LorenzoLibrary and Information Services, Hospital Universitario del Sureste, 28500 Arganda del Rey, Madrid, Spain.ORCID 0000-0002-1767-586X
Beatriz Álvarez-RodríguezDepartment of Radiation Oncology, Hospital Universitario HM Sanchinarro, HM Hospitales, HM CIOCC Centro Integral Oncológico Clara Campal, 28050 Madrid, Spain.
Alberto Martinez de LaraDrug Development and Phase I Unit, START-CIOCC, University Hospital HM Sanchinarro, 28050 Madrid, Spain.
Fernanda HerreraRadiation Oncology Service, Department of Oncology, Lausanne University Hospital, 1011 Lausanne, Switzerland.ORCID 0000-0001-7984-0472
Judith KroepDepartment of Medical Oncology, Leiden University Medical Center, 2333 Leiden, The Netherlands.ORCID 0000-0003-2671-1903
Ainhoa MadariagaDepartment of Medical Oncology, 12 de Octubre University Hospital, 28041 Madrid, Spain.ORCID 0000-0001-7166-9762

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

endometrial cancerfertility-sparing treatmentmolecular classificationobjective response rate

Identifiers

PMID42588657
PMCPMC13465110

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.